消化道出血患者药物治疗体会  

Experience of drug treatment in patients with gastrointestinal bleeding

作　　者：杨倩 

机构地区：[1]河南省桐柏县人民医院,河南桐柏474750

出　　处：《中国医药科学》2014年第8期188-190,共3页China Medicine And Pharmacy

摘　　要：目的：研究消化道出血患者的病因与药物治疗效果。方法回顾性分析2010年3月～2013年3月我院收治的消化道出血患者136例的临床资料。观察及分析患者的发病原因，以及泮托拉唑钠、奥曲肽与氨甲苯酸联合治疗的临床效果。结果136例患者的病因依次为消化性溃疡、急性胃黏膜病变、肝硬化食管静脉曲张破裂与胃癌。发病诱因为饮食不当、饮酒、药物、精神因素与劳累等因素。实施泮托拉唑钠、奥曲肽、氨甲苯酸联合治疗消化性溃疡的优良率为95.9%，治疗急性胃黏膜病变的优良率为93.3%，治疗肝硬化食管静脉曲张破裂的优良率为90.9%，治疗胃癌的优良率为100%。结论消化道出血疾病的病因是消化性溃疡，诱因常是口服刺激性的药物。采用泮托拉唑钠、奥曲肽、氨甲苯酸联合治疗消化道出血具有较高的应用价值，值得临床进一步推广应用。Objective To study the etiology and clinical efficacy of drug treatment on patients with gastrointestinal hemorrhage. Methods Clinical data of 136 cases with gastrointestinal bleeding from March 2010 to March 2013 in our hospital were retrospectively analyzed.Aetiological agent and clinical efficacy of pantoprazole sodium, octreotide combined with aminomethylbenzoic acid treatment were observed and analyzed. Results The causes of 136 cases of patients were peptic ulcer, acute gastric mucosal lesion, cirrhosis esophageal varices and gastric cancer. The predisposing factors were improper diet, alcohol, drugs, mental factors and fatigue factors. The excellent and good rate of implementation of pantoprazole sodium, omeprazole, combined with aminomethylbenzoic acid for peptic ulcer was 95.9%, the excellent and good rate of treatment of acute gastric mucosal lesion was 93.3%, the excellent and good rate for liver cirrhosis with esophageal varices was 90.9%, and the excellent and good rate of gastric cancer was 100%. Conclusion The causes of hemorrhage of digestive tract diseases are peptic ulcer, predisposing factors usually are oral irritation. Omeprazole,pantoprazole sodium combined with aminomethylbenzoic acid for gastrointestinal bleeding shows a high application value, worthy of further promotion and application.

关 键 词：消化道出血 泮托拉唑钠 奥曲肽 氨甲苯酸 

分 类 号：R573.2[医药卫生—消化系统]